Lyka Labs share news, announcements and annual reports
NSE: LYKALABSBSE: 500259Pharmaceuticals & BiotechnologySmall Cap
Lyka Labs Limited · Face value ₹10 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Jun 1986 on BSE, Feb 1995 on NSE
Last close ₹75.07down ₹1.53 (2.00%)BSE ₹75.50
Share price at the NSE close on 2 Nov 2026. Previous close ₹76.60.
2 Nov: open ₹76.00, high ₹76.00, low ₹75.07
52-week range of traded prices to 2 Nov 2026
₹44.10Low, 30 Mar 2026₹96.00High, 6 Nov 2025
- Delivery only: shares bought must be paid for in full, with no selling on the same day.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹271 Cr2,310th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- Lossover the last 12 months
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 2.83
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- −4.5%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- −3.6%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Sep 2026.
- 0.47
- Volume, NSEVolume. Shares traded on the last trading day. Volume in the glossary
- 15,895
Lyka Labs share news and announcements
1,493 announcements, routine notices left out, newest first. Page 24 of 30.
Dec 2014
19 Dec · Lyka Labs Ltd has informed BSE that the Register of Members & Share Transfer Books of the Company will remain closed from December 24, 2014 to December 26, 2014 (both days inclusive) for ....
Fixes Book Closure for AGM18 Dec · Board Meeting Adjourned
Board Meeting of the Company to be held on December 17, 2014 for the purpose of issue of shares/Warrants/any other securities on Preferential basis. The Company has now informed the Exchange that the meeting of Board of Directors has been adjourned to December 24, 2014 due to inadequate quorum.18 Dec · Business
Board Meeting Adjourned to Dec 24, 201412 Dec · Lyka Labs Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on December 17, 2014 to consider issue of further Shares / Warrants / any other securities ....
Board Meeting on Dec 17, 201412 Dec · Board meeting
To consider issue of further Shares / Warrants / any other securities on Preferential basis to Promoter / Promoter Group / Others.
Nov 2014
4 Nov · Board meeting
To consider and take on record Unaudited Standalone Financial Results for the First Quarter ended September 30, 2014.
Oct 2014
14 Oct · Shareholding Pattern For September 30, 2014
Sep 2014
29 Sep · Business
Sale of Manufacturing Facilities at Tarapur26 Sep · Updates
Company have concluded Agreement for Sale of Formulation Manufacturing Facilities located at MIDC, Tarapur Industrial Area, Boisar, Maharashtra for consideration of Rs. 38.61 crores.23 Sep · Updates on Consolidated Statement of Assets & Liabilities for June 30, 2014
Aug 2014
20 Aug · Board meeting
To consider and take on record Audited Standalone and Consolidated Financial Results for the Fifth Quarter and year of 15 months ended 30.06.2014 and also to consider and take on record Restatement of Accounts for the Financial Year 2012-13.
Jul 2014